"GRAIL Partners with Samsung for Strategic Collaboration and Investment to Expand Cancer Detection Technology in Asia"
"Latham & Watkins advised GRAIL, Inc. in a strategic collaboration with Samsung C&T and Samsung Electronics to expand GRAIL's Galleri multi-cancer early detection test into key Asian markets. As part of this collaboration, Samsung companies will invest $110 million in GRAIL. Additionally, Latham & Watkins assisted GRAIL in a $325 million private placement financing with institutional investors. The advisory team included partners and associates from various Latham & Watkins offices, providing expertise in collaboration, intellectual property, regulatory, and tax matters."